Introduction {#s1}
============

Fast, saltatory nerve impulse conduction in the central nervous system (CNS) of vertebrates is facilitated by the ensheathment of axons with multiple layers of insulating oligodendroglial membrane, termed myelin ([@bib51]; [@bib27]). Myelin compaction along the extracellular membrane surface (intraperiod line) involves cholesterol-associated transmembrane proteins, such as proteolipid protein (PLP) ([@bib64]; [@bib72]), which exhibits adhesive forces ([@bib3]; [@bib6]) that prevent splitting of myelin lamellae ([@bib45]; [@bib48]; [@bib60]). At the intracellular membrane surface (major dense line), myelin basic protein (MBP) facilitates the tight association of myelin layers by covering the negatively charged headgroups of membrane phospholipids ([@bib50]; [@bib52]; [@bib53]). The adhesive function of MBP can be counteracted by the presence of cyclic nucleotide phosphodiesterase (CNP), thereby regulating the developmental closure of cytoplasmic channels that flank compacted myelin ([@bib66]). In mature myelin, CNP is thus largely confined to non-compacted myelin ([@bib8]; [@bib71]). The relevance of PLP, MBP and CNP for the regular ultrastructure of myelin is reflected by their high abundance in biochemically purified myelin membranes ([@bib31]) and the myelin defects in the corresponding mouse mutants.

In addition to the delamination of single myelin layers, pathological destabilization of myelin was observed as pathological outfoldings of entire stacks of compacted myelin membranes in several myelin mutants, ([@bib55]) and upon normal brain aging ([@bib58]; [@bib67]). We recently found that myelin outfoldings correlate with a loss of septins, which are cytoskeletal proteins of comparatively lower abundance in the myelin proteome ([@bib55]). Septins are widely expressed and control the rigidity of the membranes they are associated with ([@bib7]; [@bib25]). Localized in the non-compacted, adaxonal myelin layer adjacent to the inner-most compacted myelin membrane, myelin septin filaments are assembled from the monomers SEPT2, SEPT4, SEPT7 and SEPT8 in 1:1:2:2 stoichiometry ([@bib55]). This marks a canonical but distinct composition of subunits when compared with the higher order structures of septins in other cell types ([@bib4]; [@bib16]). Recently, we proposed that septin filaments provide a scaffold that prevents detachment of the compacted myelin layers from the adaxonal myelin membrane and thus outfoldings of entire myelin sheaths ([@bib55]).

Septins associate with the pleckstrin homology (PH)-domain containing adaptor protein anillin (ANLN) and its homologs in drosophila embryos ([@bib18]; [@bib21]; [@bib44]), budding yeast ([@bib19]; [@bib35]; [@bib68]) and mouse NIH3T3-fibroblasts ([@bib36]). Here, the role of anillin in the formation of contractile septin rings is a conserved step of cytokinesis ([@bib59]) and essential for cell division ([@bib76]). However, in post-mitotic cells the interactions between septins and anillin are not understood. In the adult CNS, expression of *Anln* mRNA is highest in myelinating oligodendrocytes when assessed by RNA-Seq ([www.web.stanford.edu/group/barres_lab/cgi-bin/igv_cgi_2.py?lname=anln](http://www.web.stanford.edu/group/barres_lab/cgi-bin/igv_cgi_2.py?lname=anln)) ([@bib77]), single-cell transcriptomics ([www.linnarssonlab.org/cortex](http://www.linnarssonlab.org/cortex)) ([@bib75]) and in situ-hybridization ([mouse.brain-map.org/gene/show/44585](http://mouse.brain-map.org/gene/show/44585)) ([@bib42]).

Here we show that oligodendroglial anillin serves a crucial function in myelination. Conditional mouse mutants lacking expression of the *Anln*-gene in mature oligodendrocytes fail to assemble septin filaments, display large myelin outfoldings similar to those of *Sept8*-mutant mice ([@bib55]) and exhibit reduced nerve conduction velocity. This work thus establishes a crucial function for anillin-dependent assembly of myelin septin filaments in scaffolding CNS myelin to enable rapid nerve conduction, thereby demonstrating a vital function of anillin unrelated to cytokinesis.

Results and discussion {#s2}
======================

To address a functional connection between anillin and myelin septins, we first asked if the protein is also enriched in CNS myelin. Indeed, anillin was detected in myelin when biochemically purified from mouse brains at P75, while it was virtually undetectable in brain lysates when loading the same amount of protein ([Figure 1A](#fig1){ref-type="fig"}). This implies that anillin is enriched in myelin similar to SEPT8 variant 1 (SEPT8_v1; according to nomenclature at Ensembl.org) ([@bib55]) or myelin oligodendrocyte glycoprotein (MOG) ([@bib43]). In comparison, the axonal marker Tubulin-beta3/TUJ1 was diminished in myelin compared to brain lysate ([Figure 1A](#fig1){ref-type="fig"}). To determine the localization of anillin, we performed immunohistochemistry and confocal microscopy of longitudinal spinal cord sections. We found that anillin-immunolabeling parallels but does not overlap with axonal neurofilament (NF) labeling ([Figure 1B](#fig1){ref-type="fig"}). Most anillin-immunolabeling was reminiscent of the longitudinal myelin septin filaments ([Figure 1C](#fig1){ref-type="fig"}) ([@bib55]).

![Co-distribution of anillin with myelin septins.\
(**A**) Immunoblotting of myelin purified from the brains of wild type mice at P75 compared to brain lysates indicates that anillin (ANLN) is enriched in myelin similar to septin 8 variant 1 (SEPT8_v1). The same amount of protein was loaded. The myelin marker MOG and the axonal marker TUJ1 served as controls. Blot shows n = 2 mice per genotype representative of n = 3 mice per genotype. (**B--C**) Immunofluorescent signal of ANLN (green in **B**) and SEPT7 (green in **C**) extends longitudinally along axons identified by neurofilament-labelling (red in **B--C**). Additional ANLN-immunopositive puncta (asterisks in **B**) were not evidently associated with filamentous structures (arrowheads in **B,C**). The panels show maximal projections of confocal stacks and 3-dimensional reconstructions of longitudinally sectioned spinal cord of P75 WT mice. Images representative of three mice. (**D**) Immunoblotting of myelin purified from the brains of wild-type mice at P15, P18, P21 and P24 indicates that the abundance of ANLN in myelin increases with maturation. Myelin septins (SEPT2, SEPT4, SEPT7, SEPT8) and MAG served as control. Blot shows n = 1 mouse per timepoint. (**E**) Immunolabelling of longitudinally sectioned WT optic nerves detects ANLN (red) in proximity to SEPT8 (green); co-labeled structures (arrowheads) were seen occasionally at P21 and frequently at P28 but not at P15. TUJ1 served as axonal marker. Images representative of three experiments.](elife-43888-fig1){#fig1}

Considering that the abundance of *Anln* mRNA increases over 10-fold coinciding with the differentiation of oligodendrocyte progenitor cells to myelinating oligodendrocytes ([@bib77]) we tested whether the abundance of ANLN increases with the developmental maturation of myelin. Indeed, by immunoblotting of myelin purified from mouse brains at postnatal day 15 (P15), P18, P21 and P24, the abundance of ANLN increased ([Figure 1D](#fig1){ref-type="fig"}) similar to that of SEPT2. When immunolabeling ANLN together with SEPT8 on longitudinal optic nerve sections at P15, P21 and P28, first co-labeled structures were occasionally detected at P21 but frequently seen at P28 ([Figure 1E](#fig1){ref-type="fig"}). Also in other white matter tracts, ANLN-immunolabeling was largely in proximity to SEPT8-immunolabeling, as seen in the fimbria and the corpus callosum by immunohistochemistry of coronal brain sections from wild type mice at P75 ([Figure 1---figure supplement 1A,B](#fig1s1){ref-type="fig"}). Thus, expression of the cytoskeletal adaptor protein ANLN is strongly enriched in mature oligodendrocytes, in which it largely co-distributes with myelin septin filaments that localize to the non-compacted adaxonal myelin layer.

We previously noted that the presence of pathological myelin outfoldings in several myelin mutant mice correlates with reduced abundance of both myelin septins and ANLN ([@bib55]). However, it remained unknown whether diminishment of ANLN represents a mere epiphenomenon of septin loss or if ANLN has a function in the assembly of septin filaments. To discriminate between these alternative hypotheses, we generated mouse mutants in which exon 4 of the *Anln* gene is flanked by loxP-sites ([Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}). Appropriate breedings yielded *Anln^flox/flox^;Cnp^Cre/WT^* mice, in which Cre recombinase is expressed under control of the *Cnp* promoter ([@bib40]) to mediate recombination ([Figure 2---figure supplement 1B](#fig2s1){ref-type="fig"}) in myelinating oligodendrocytes. Conditional mutants and control mice were born at the expected frequencies, and the major white matter regions developed normally as judged by light microscopic visualization of myelin upon silver impregnation ([Figure 2A,A](#fig2){ref-type="fig"}'). However, electron microscopic analysis revealed the presence of numerous myelin outfoldings in the CNS of *Anln^flox/flox^;Cnp^Cre/WT^* mice ([Figure 2B,C](#fig2){ref-type="fig"}), very similar to *Sept8^null/null^* and *Sept8^flox/flox^;Cnp^Cre/WT^* mutants ([@bib55]). Analysis of myelin sheath thickness ([Figure 2D,D](#fig2){ref-type="fig"}'), the percentage of myelinated axons ([Figure 2E](#fig2){ref-type="fig"}), degenerating/degenerated axons ([Figure 2F](#fig2){ref-type="fig"}) and secondary neuropathology ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}) did not reveal further abnormalities in *Anln^flox/flox^;Cnp^Cre/WT^* mice, implying that myelin outfoldings represent a very specific neuropathology.

![Myelin outfoldings and reduced nerve conduction velocity in mice lacking oligodendroglial expression of ANLN.\
(**A--A'**) Silver impregnation (in brown) visualizes myelinated fiber tracts in mice lacking ANLN from myelinating cells (*Anln^fl/fl^;Cnp^Cre/WT^*-mice; *Anln* cKO) and in control mice (*Anln^fl/fl^*) at P75. (**A**) displays coronal brain sections; **A'**) shows sagittal sections through the cerebellum. Images representative of three mice per genotype. For generation and validation of *Anln* cKO mice see [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}. (**B**) Electron micrographs of optic nerves exemplify myelin outfoldings at P75. Stippled lines highlight myelin outfoldings; associated axons are marked with asterisks. (**C**) Quantitative evaluation of electron micrographs of optic nerves reveals progressive emergence of myelin outfoldings in adult *Anln^fl/fl^;Cnp^Cre/WT^* mice (*Anln* cKO). Mean +/SEM. n = 4--6 mice per genotype and age; two-tailed unpaired t-test P14 p=0.0076; P75 p=0.0009; 6mo p=0.0007. (**D,D'**) g-ratio analysis of electron micrographs of optic nerves at six mo indicates normal myelin sheath thickness in *Anln* cKO mice. Mean +/SEM. Not significant according to two-way ANOVA (p=0.9279). (**E**) Quantitative evaluation of electron micrographs of optic nerves at six mo reveals a normal frequency of myelinated axons in *Anln* cKO mice. Mean +/SEM. n = 4--5 mice per genotype; not significant (n.s.) according to two-tailed unpaired t-test (p=0.1827). (**F**) Quantitative evaluation of electron micrographs of optic nerves at six mo indicates that there is no increased frequency of degenerating/degenerated axons in *Anln* cKO mice. Mean +/SEM. n = 4--5 mice per genotype; not significant (n.s.) according to two-tailed unpaired t-test (p=0.8664). For immunohistochemical assessment of neuropathology see [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}. (**G**) Electrophysiological measurement reveals reduced nerve conduction velocity in the spinal cord of *Anln* cKO compared to control (*Anln^fl/fl^*) mice at six mo. Mean +/SEM. n = 7--11 mice per genotype; two-tailed unpaired t-test (p=0.0149). For assessment of density and dimensions of the nodes of Ranvier see [Figure 2---figure supplement 3](#fig2s3){ref-type="fig"}.](elife-43888-fig2){#fig2}

To test if myelin outfoldings in *Anln^flox/flox^;Cnp^Cre/WT^* mice impair CNS function in vivo, we measured nerve conduction in the spinal cord at 6 months of age. Indeed, nerve conduction velocity was reduced by 15.5% in *Anln^flox/flox^;Cnp^Cre/WT^* compared to control mice ([Figure 2G](#fig2){ref-type="fig"}), very similar to *Sept8*-mutants ([@bib55]). Considering that slowed nerve conduction can be caused by structural changes of the nodes of Ranvier ([@bib2]) we performed immunohistochemistry for the nodal and paranodal markers Nav1.6 and CASPR, respectively, and determined the density of the nodes ([Figure 2---figure supplement 3A](#fig2s3){ref-type="fig"}) as well as their length and diameter (as indicated in [Figure 2---figure supplement 3B](#fig2s3){ref-type="fig"}). This analysis did not reveal any nodal or paranodal abnormality in *Anln^flox/flox^;Cnp^Cre/WT^* mice ([Figure 2---figure supplement 3C--F](#fig2s3){ref-type="fig"}). Although we cannot formally rule out other unidentified alterations in the CNS of *Anln^flox/flox^;Cnp^Cre/WT^* mice, myelin outfoldings are the most likely cause of reduced nerve conduction velocity.

At the molecular level we asked whether recombination of the *Anln*-gene in mature oligodendrocytes affects the protein composition of myelin. As expected, ANLN was undetectable by immunoblot analysis of myelin purified from the brains of *Anln^flox/flox^;Cnp^Cre/WT^* mice ([Figure 2---figure supplement 1C](#fig2s1){ref-type="fig"}). Interestingly, in these mutants the abundance of SEPT8 in myelin was reduced ([Figure 2---figure supplement 1C](#fig2s1){ref-type="fig"}). This prompted us to analyze the entire myelin proteome by quantitative label-free mass spectrometry ([Figure 3---source data 1](#fig3sdata1){ref-type="supplementary-material"}). ANLN was readily detectable in myelin purified from the brains of control mice but not identified in *Anln^flox/flox^;Cnp^Cre/WT^* myelin ([Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}). The abundance of all myelin septins (SEPT2, SEPT4, SEPT7, SEPT8) was strongly reduced in myelin purified from the brains of *Anln^flox/flox^;Cnp^Cre/WT^* mice ([Figure 3A,B](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"}). Interestingly, the abundance of two GTPases of the Rho-subfamily, CDC42 and RHOB, also appeared reduced, although less than the applied threshold of a 2-fold change ([Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"}). Importantly, the abundance of the major myelin marker proteins ([Figure 3---figure supplement 1C](#fig3s1){ref-type="fig"}, [Figure 3C](#fig3){ref-type="fig"}) and cytoskeletal proteins associated with the actin cytoskeleton or microtubules ([Figure 3---figure supplement 1D](#fig3s1){ref-type="fig"}) was unaltered.

![Myelin composition in mice lacking oligodendroglial expression of ANLN.\
(**A**) Volcano plot summarizing genotype-dependent quantitative myelin proteome analysis. Data points represent quantified proteins in myelin purified at P75 from the brains of *Anln* cKO compared to *Anln^fl/fl^* mice (n = 3 mice per genotype). Data points are plotted as log2-transformed fold-change (FC) on the x-axis against the −log10-transformed q-value on the y-axis. The horizontal red dashed line indicates a q-value of q = 0.01; the vertical black dashed lines mark the ±1 log2 fold-change threshold indicating a halved or doubled abundance of a protein in myelin, respectively. Data points representing myelin septin monomers (SEPT2, SEPT4, SEPT7, SEPT8) are highlighted in light red color with protein names given; note that their abundance is strongly reduced in *Anln* cKO compared to *Anln^fl/fl^* myelin. Also note that ANLN is not represented because it was not detected in *Anln* cKO myelin. For bar graphs showing genotype-dependent comparison of the abundance of individual proteins in myelin see [Figure 3---figure supplement 1A--D](#fig3s1){ref-type="fig"}. For the original dataset and exact q-values see [Figure 3---source data 1](#fig3sdata1){ref-type="supplementary-material"}. (**B**) Immunoblotting validates the lack of anillin (ANLN) and the strong reduction of septins (SEPT2, SEPT4, SEPT7, SEPT8) in myelin purified from the brains of *Anln* cKO-mice. ATPase Na+/K + transporting subunit alpha 3 (ATP1A3) was detected as control. Blot shows n = 3 mice per genotype. (**C**) Immunoblotting indicates that the abundance of classical myelin proteins (PLP/DM20, SIRT2, CD9, CA2) is unaltered in myelin purified from the brains of *Anln* cKO-mice. ATP1A1 served as control. Blot shows n = 3 mice per genotype. (**D**) Genotype-dependent quantitative assessment of PtdIns(4,5)P~2~ (PIP~2~)--levels in myelin purified from the brains of *Anln* cKO-mice compared to controls (*Anln^fl/fl^*) at P75. Mean +/SEM. n = 6 mice per genotype; two-tailed unpaired t-test; PtdIns(4,5)P~2~p=0.0435. (**E**) qRT-PCR to determine the abundance of mRNAs encoding anillin and myelin septins in the white matter (corpus callosum) of control (*Anln^fl/fl^*) versus *Anln* cKO-mice. Note that *Anln* mRNA was virtually undetectable in *Anln* cKO-mice while the abundances of *Sept2*, *Sept4*, *Sept7* and *Sept8* mRNAs were unaltered. Mean +/SEM. n = 6 mice per genotype; two-way ANOVA; *Anln* p\<0.0001, *Sept2* p\>0.9999, *Sept4* p\>0.9999, *Sept7* p\>0.9999, *Sept8* p\>0.9999.\
10.7554/eLife.43888.010Figure 3---source data 1.Label-free quantification of proteins in myelin purified from the brains of Anln cKO and control mice Tryptic peptides derived from two technical replicates (replicate digestion) per biological replicate (n = 3 mice per genotype) were analyzed by LC-MS (12 runs in total).Proteins (FDR \< 1%; two peptides/protein) and peptides (FDR \< 1%;≥6 amino acids) were identified by database search against the UniprotKB/SwissProt mouse database using PLGS. Data were post-processed with the software package ISOQuant to calculate absolute in-sample amounts for each detected protein based on the TOP3 approach. Reported abundance values are defined as the relative amount of each protein in respect to the sum over all detected proteins (ppm: parts per million (w/w) of total protein). The typical contaminant proteins trypsin and keratins were filtered. One technical replicate of a control sample was identified as outlier based on its low correlation coefficient of ≤0.76 (all other runs ≥ 0.95) and thus excluded from analysis.](elife-43888-fig3){#fig3}

Since a reduction of the membrane phospholipid phosphatidylinositol (4,5)-bisphosphate (PtdIns(4,5)P~2~) in myelin of *Pten^flox/flox^;Cnp^Cre/WT^* mice causes a loss of septins and ANLN ([@bib55]), we asked whether *vice versa* the absence of ANLN from myelin affects PtdIns(4,5)P~2~--levels. Indeed, by quantitative assessment of label-free lipid extracts ([@bib26]; [@bib37]) we found a decreased abundance of PtdIns(4,5)P~2~ in myelin purified from the brains of *Anln^flox/flox^;Cnp^Cre/WT^* compared to control mice ([Figure 3D](#fig3){ref-type="fig"}).

By qRT-PCR, cDNA-fragments for *Sept2*, *Sept4*, *Sept7, Sept8* were amplified with equal efficiency from mutant and control corpus callosi ([Figure 3E](#fig3){ref-type="fig"}), suggesting that the loss of myelin septins is a posttranscriptional event secondary to ANLN-deficiency. Most likely, myelin septin monomers are degraded if not incorporated into filamentous higher order structures, the formation of which is facilitated by ANLN. The cDNA-fragments for *Rhob and Cdc42* were also amplified with equal efficiency from mutant and control corpus callosi ([Figure 3---figure supplement 1E](#fig3s1){ref-type="fig"}). Conversely, cDNA fragments for *Anln* were virtually undetectable in *Anln^flox/flox^;Cnp^Cre/WT^* corpus callosi ([Figure 3E](#fig3){ref-type="fig"}), indicating that expression of *Anln* mRNA in the adult CNS is strongly enriched in mature oligodendrocytes in accordance with RNA-Seq data ([@bib75]; [@bib77]).

To determine the morphology of myelin outfoldings three-dimensionally, we performed focused ion beam-scanning electron microscopy (FIB-SEM) of optic nerves dissected from *Anln^flox/flox^;Cnp^Cre/WT^* and control mice, covering a depth of about 23 µm in each tissue. In control nerves, reconstruction of axonal plasma membranes (false-colored in blue in [Figure 4](#fig4){ref-type="fig"}) and myelin (false-colored in yellow in [Figure 4](#fig4){ref-type="fig"}) revealed a largely regular association of myelinated axons with their myelin sheaths (exemplified in [Figure 4A,A'](#fig4){ref-type="fig"} and [Video 1](#video1){ref-type="video"}). In comparable blocks of optic nerves dissected from *Anln^flox/flox^;Cnp^Cre/WT^* mice, FIB-SEM allowed the 3D-reconstruction of a number of myelin outfoldings ([Figure 4B',B'''](#fig4){ref-type="fig"} and [Video 2](#video2){ref-type="video"} and [Video 3](#video3){ref-type="video"}). Most of them were in internodal segments; we observed only a single myelin outfolding close to a node of Ranvier. The observed myelin outfoldings measured between 10 µm and 15 µm in length. Thus, myelin outfoldings do not adopt pin-needle-like shape but represent large sheets of compacted multilayered membrane stacks that extend for considerable distance away from the myelinated axon.

![Three-dimensional reconstruction of myelin outfoldings in Anln cKO mice.\
(**A--C**) Focused ion beam-scanning electron microscopy (FIB-SEM) micrographs and 3D reconstruction of the plasma membrane of myelinated axonal segments (blue) and respective myelin sheaths (yellow) of representative axon/myelin-units in the optic nerve of control (*Anln^fl/fl^*) (**A,A'**) and *Anln* cKO (**B,B',B'',B'''**) mice at 5.5 mo. Note the tight association of the myelin sheath reconstructed in A **'**with the corresponding axon (in **A,A'**) over at least 10 µm in the control nerve. An individual myelin outfolding (**B'**) and the corresponding axon are reconstructed over 20 µm in B,B'. All myelin outfoldings in that same block (as in **B,B'**) were reconstructed in B''' with their corresponding axons (in **B'',B'''**). Note that myelin outfoldings represent large sheets of compacted multilayered membrane stacks that extend considerably away from their respective myelinated axon, commonly displaying longitudinal dimensions between 10 µm and 15 µm. See [Videos 1](#video1){ref-type="video"}--[3](#video3){ref-type="video"}.](elife-43888-fig4){#fig4}

###### FIB-SEM and 3D reconstruction of a normal-appearing axon/myelin-unit in a control mouse.

10.7554/eLife.43888.012

###### FIB-SEM and 3D reconstruction of one selected myelin outfolding in an *Anln* cKO mouse.

10.7554/eLife.43888.013

###### FIB-SEM and 3D reconstruction of multiple myelin outfoldings in one tissue block of an *Anln* cKO mouse.

10.7554/eLife.43888.014

Outfoldings of compact CNS myelin are a neuropathological hallmark in numerous models of myelin-related disorders ([@bib55]) and upon normal brain aging ([@bib58]; [@bib67]). Localized in the non-compacted adaxonal myelin layer, i.e. underlying the innermost compact myelin membrane, septin filaments scaffold the myelin structure, thereby preventing the emergence of myelin outfoldings ([@bib55]). The phenotype of *Anln^flox/flox^;Cnp^Cre/WT^* mice is very similar to that of mice lacking SEPT8, a septin monomer essential for the assembly of myelin septin filaments ([@bib55]). Thus, the present study has revealed that anillin is critical for the assembly of septin filaments in CNS myelin and that the lack of these filaments causes myelin outfoldings associated with reduced nerve conduction velocity.

During yeast cytokinesis, PtdIns(4,5)P~2~ recruits the anillin homolog Mid2p to the membrane at the cleavage furrow, which in turn is critical for the polymerization of septin subunits into rings at the budding site of mother and daughter cells ([@bib5]; [@bib44]). At the molecular level, the interactions between PtdIns(4,5)P~2~, anillin and septins are probably principally conserved between dividing cells and mature oligodendrocytes, which are post-mitotic. Yet, during cytokinesis, ANLN affects microtubules and myosin-dependent bundling of actin filaments ([@bib28]; [@bib29]). Since myelin wrapping involves actin disassembly ([@bib54]; [@bib78]) and myelin compaction requires trafficking of *Mbp* mRNA along microtubules ([@bib49]; [@bib69]), we point out that there is no evidence of fewer, thinner or non-compacted myelin sheaths in *Anln^flox/flox^;Cnp^Cre/WT^* mice. Instead, ANLN is required during the latest stages of myelin maturation, i.e., for septin-dependent scaffolding of the myelin sheath rather than for its actin/tubulin-dependent biosynthesis and compaction.

Myelin is one of the most long-lived structures in the CNS ([@bib70]) with a particularly slow turnover rate of its components ([@bib41]; [@bib46]; [@bib73]; [@bib74]). Failure to physically stabilize the myelin architecture causes myelin outfoldings and affects nerve conduction velocity. We therefore propose that PtdIns(4,5)P~2~/anillin-dependent scaffolding of myelin by septin filaments represents a crucial step of myelin maturation.

Materials and methods {#s3}
=====================

Mouse models {#s3-1}
------------

Embryonic stem cells (ES) harboring an engineered allele of the *Anln* gene were acquired from the European Conditional Mouse Mutagenesis Program (Eucomm). ES were microinjected into blastocysts derived from c57BL/6N mice, and embryos were transferred to pseudo-pregnant foster mothers, yielding two chimeric males. For ES clone EPD0545_1\_F09, germline transmission was achieved upon breeding with c57BL/6N-females, yielding mice harboring the *Anln^LacZ-neo^* allele. The lacZ-neo cassette was excised in vivo upon interbreeding with mice expressing FLIP recombinase (*129S4/SvJaeSor-Gt(ROSA)26Sor^tm1(FLP1)Dym/J^*; backcrossed into c57BL/6N), yielding mice carrying the *Anln^flox^* allele. To inactivate expression of ANLN in myelinating cells, exon four was excised in vivo upon appropriate interbreedings of *Anln^flox^* mice with mice expressing Cre recombinase under control of the *Cnp* promoter ([@bib40]). For simplicity, *Anln^fl/fl^;Cnp^Cre/WT^* mice are also termed *Anln* conditional knockout (*Anln* cKO). Routine genotyping of the *Anln* allele as shown in [Figure 2---figure supplement 1B](#fig2s1){ref-type="fig"} was performed by PCR with sense primer P1 (5'-GACATAGCCC TCAGTGTTCAGG; binding 5 'of the first loxP-site) in combination with antisense primers P2 (5'-GAATCCTGCA TGGACAGACAG; binding the segment flanked by loxP-sites), and P3 (5'-GAGCTCAGAC CATAACTTCG; binding 3 'of the third loxP site). PCR genotyping of the *Cnp* allele was with primers *2016* (5'-GCCTTCAAAC TGTCCATCTC), *7315* (5'-CCCAGCCCTT TTATTACCAC), *4193* (5'-CCTGGAAAAT GCTTCTGTCCG) and *4192* (5'-CAGGGTGTTA TAAGCAATCCC). Experimental mutant mice were analyzed together with littermate controls as far as possible. Mice were kept in the mouse facility of the Max Planck Institute of Experimental Medicine with a 12 hr light/dark cycle and 2--5 mice per cage. All experiments were approved by the Niedersächsisches Landesamt für Verbraucherschutz und Lebensmittelsicherheit (license 33.19-42502-04-15/1833) in agreement with the German Animal Protection Law.

Quantifications and statistical analysis {#s3-2}
----------------------------------------

Sample size was according to previous analyses of similar parameters, e.g. in ([@bib55]). All quantifications were performed blinded with respect to the genotypes. Bar graphs display mean values and standard error of the mean (SEM). Statistical tests were performed in GraphPad Prism 6.0. Tests were chosen depending on experimental groups and as suggested by the software. To test for variance, F-test was performed in GraphPad Prism 6.0. GraphPad online test at <http://graphpad.com/quickcalcs/Grubbs1.cfm> was used to test for outliers; however, no outliers were removed from the data. Levels of significance were set at p\<0.05 (\*), p\<0.01 (\*\*), and p\<0.001 (\*\*\*). Exact p-values are given in the figure legends. For myelin proteome analysis, q-values were calculated by R data analysis as detailed in the section 'Myelin proteome analysis' and given in [Figure 3---source data 1](#fig3sdata1){ref-type="supplementary-material"}.

Electron microscopy {#s3-3}
-------------------

For conventional transmission electron microscopy, sample preparation by chemical fixation or by high pressure freezing and freeze substitution was performed as described ([@bib47]; [@bib48]; [@bib55]; [@bib56]). Myelinated and degenerated axons were assessed on electron micrographs of the optic nerves of 4--5 male mice per genotype chemically fixed at 6 mo of age. 15 randomly distributed non-overlapping electron micrographs were taken per optic nerve at 7000x magnification (one field = 220 µm²). Electron micrographs were assessed using ImageJ (Fiji) ([@bib62]). A minimum of 1600 axons per mouse was assigned to one of three categories: healthy-appearing myelinated axons, healthy-appearing non-myelinated axons and degenerating/degenerated profiles. Axons were counted as myelinated if ensheathed by at least one complete layer of compact myelin. Degenerating/degenerated profiles were identified by the presence of tubovesicular structures and amorphous cytoplasm within an axon or the absence of an identifiable axon within a myelin sheath, respectively. The area occupied by myelin outfoldings was assessed by applying a point-hit counting method ([@bib17]; [@bib55]) to the same electron micrographs. Briefly, a regular grid of 0.25 µm^2^ was placed on the images. The number of intercepts coinciding with myelin outfoldings was related to the evaluated area. g-ratios were calculated as ratio between axonal Feret diameter and Feret diameter of the corresponding myelin sheath. To this aim, the top left quarter of the same electron micrographs (one field = 55 µm²) was assessed, yielding a minimum of 200 myelinated axons per mouse.

For focused ion beam-scanning electron microscopy (FIB-SEM), optic nerves dissected from mice at 5.5 months of age were fixed for 24 hr in 4% formaldehyde (Serva) and 2.5% glutaraldehyde (Science Services) in 0.1 M phosphate buffer (PB). The samples were processed principally following the OTO protocol ([www.ncmir.ucsd.edu/sbem-protocol](http://www.ncmir.ucsd.edu/sbem-protocol)) ([@bib12]) with some modifications: Samples were washed in 0.1 M PB (3 × 15 min), incubated for 3 hr at 4°C in 2% osmium tetroxide (OsO~4~) (Electron Microscopy Sciences) and 0.25% potassium ferrocyanide (K~4~\[Fe(CN)~6~\]) (Electron Microscopy Sciences), washed with H~2~O (3 × 15 min) and then incubated with 0.1% thiocarbohydrazide (Sigma-Aldrich) for 1 hr at room temperature. For further contrast enhancement the tissue was treated with 2% OsO~4~ for 90 min at room temperature. The samples were then washed with H~2~O (3 × 15 min), contrasted overnight at 4°C with 2% uranyl acetate (SPI-Chem) and washed again with H~2~O (3 × 15 min), followed by dehydration in an increasing acetone series (30%, 50%, 75%, 90%, 3 × 100%). The tissue was infiltrated with increasing concentrations of Durcupan (Sigma-Aldrich, components A, B, C) for 2 hr each (25%, 50%, 75% Durcupan in acetone) and then incubated in 100% Durcupan overnight. Fresh Durcupan with accelerator (component D) was added to the samples for 5 hr before embedding the samples in resin blocks. The blocks were polymerized for 48 hr at 60°C.

The blocks were trimmed with a 90° diamond trimming knife (Diatome AG, Biel, Switzerland). The blocks were then attached to the SEM stub (Science Services GmbH, Pin 12.7 mm x 3.1 mm) by a silver filled epoxy resin (Epoxy Conductive Adhesive, EPO-TEK EE 129--4; EMS) and polymerized at 60° overnight. The samples were coated with a 10 nm platinum layer using the sputter coater EM ACE600 (Leica) at 35 mA current. Samples were placed into the Crossbeam 540 focused ion beam-scanning electron microscope (Carl Zeiss Microscopy GmbH). To ensure even milling and to protect the surface, a 400 nm platinum layer was deposited on top of the region of interest. Atlas 3D (Atlas 5.1, Fibics, Canada) software was used to collect the 3D data. Samples were exposed with a 15 nA current, and a 7 nA current was used to polish the surface. The images were acquired at 1.5 kV with the ESB detector (450 V ESB grid, pixel size x/y 2 nm) in a continuous mill-and-acquire mode using 700 pA for the milling aperture (z-step 50 nm).

For image analysis, alignments were done with TrackEM2 ([@bib9]), a plugin of Fiji ([@bib62]). The following post-processing steps were performed in Fiji: The dataset was cropped and inverted before applying a Gaussian blurr (sigma 2) and local contrast enhancement (CLAHE: blocksize 56; histogram bins 100; maximum slope 1.5). The images were manually segmented using IMOD ([@bib38]).

Immunohistochemistry {#s3-4}
--------------------

Immunohistochemistry on sections of paraffin-embedded brains to determine neuropathology was performed as described ([@bib11]; [@bib55]), assessing five male mice per genotype at postnatal day 75 (P75). Antibodies were specific for MAC3 (Pharmingen 553322; 1:400), glial fibrillary acidic protein (GFAP) (NovoCastra NCL-L-GFAP-GA5; 1:200) or amyloid precursor protein (APP) (Chemicon MAB348; 1:1000). For quantification, the hippocampal fimbria was selected, and APP‐positive axonal spheroids were counted. Microscopy was as described ([@bib55]). To quantify white matter area immunopositive for MAC3 or GFAP, the hippocampal fimbria was selected on micrographs and analyzed using an ImageJ plugin for semiautomated analysis ([@bib11]; [@bib45]; [@bib55]). Data were related to the mean of wild-type levels. Silver impregnation of myelin on histological sections was as described ([@bib22]; [@bib55]). Microscopy and image stitching was as described ([@bib55]).

Immunohistochemistry on cryosectioned optic nerves to assess expression and localization of ANLN and myelin septins was as described ([@bib55]). Antibodies were specific for ANLN (Acris AP16165PU-N; 1:200), SEPT7 (IBL18991; 1:1000), SEPT8 (ProteinTech Group 11769--1-AP; 1:500), TUJ1 (Covance MMS-435P; 1:1000), neurofilament (Covance SMI-31; 1:1500), myelin-associated glycoprotein (MAG clone 513; Chemicon MAB1567; 1:50), voltage-gated sodium channel Na~v~1,6 (alomonelabs ASC-009; 1:500) or contactin-associated protein (CASPR; Neuromabs 75--001; 1:500). Secondary antibodies were donkey α-rabbit-Alexa488 (Invitrogen A21206), donkey α-mouse-Alexa488 (Invitrogen A21202), donkey α-rabbit-Alexa555 (Invitrogen A31572), donkey α-mouse-Alexa555 (Invitrogen A31570), donkey α-goat-Cy3 (dianova 705-165-147) and donkey α-mouse Dyelight633 (Yo-Pro). Images were obtained by confocal microscopy (Leica SP5) as described ([@bib55]). The LAS AF lite and Fiji were used to export the images as tif-files. Imaris was used for 3D-reconstructions. For quantification of nodal density, the frequency of occurrence of two CASPR-immunopositive paranodes was analyzed using Fiji. CASPR-immunopositivity was converted using a threshold and counted using ITNC plugin (n = 4 mice per genotype, one section each, five random micrographs of spinal cord white matter with a size of 2500 µm^2^ per micrograph). Statistical analysis was performed using GraphPad Prism 6.0.

Myelin purification {#s3-5}
-------------------

A light-weight membrane fraction enriched for myelin was purified from mouse brains by sucrose density centrifugation and osmotic shocks as described ([@bib32]; [@bib55]). For immunoblot analyses of myelin during development, male wild-type (c57Bl/6N) mice were used at the indicated ages. For proteome and immunoblot analyses of *Anln* cKO mice and control (*Anln^fl/fl^*) littermates, n = 3 male mice at P75 were used. Protein concentrations were determined using the DC protein assay (BioRad). For PtdIns(4,5)P~2~ measurement, myelin was purified from n = 6 male mice per genotype at P75 with phosphatase inhibitor (Roche PhosSTOP; 1 tablet per 10 ml) added to the Tris-buffered saline and the sucrose solutions.

Myelin proteome analysis {#s3-6}
------------------------

Differential quantitative label-free proteome analysis of myelin purified from the brains of male *Anln* cKO mice and control littermates at P75 was performed using a label-free quantification workflow essentially as described ([@bib1]; [@bib55]). Briefly, protein fractions corresponding to 10 μg myelin protein were lysed and reduced in lysis buffer (7 M urea, 2 M thiourea, 10 mM DTT, 0.1 M Tris pH 8.5) containing 1% ASB-14 while shaking for 30 min at 37°C. Subsequently, samples were diluted with 10 volumes lysis buffer containing 2% CHAPS to reduce the ASB-14 concentration and processed according to an automated filter-aided sample preparation (FASP) protocol for in-solution digestion with trypsin. Aliquots of the recovered tryptic peptides were spiked with 10 fmol/μl Hi3 EColi standard (Waters Corporation) for protein quantification according to the TOP3 approach ([@bib63]). This standard contains a set of quantified synthetic peptides representing the top six ionizing tryptic peptides derived from E. coli. Chaperone protein ClpB. Peptide samples were directly subjected to analysis by liquid chromatography coupled to electrospray mass spectrometry (LC-MS) on a Synapt G2-S quadrupole time-of-flight mass spectrometer equipped with ion mobility option (Waters Corporation). Analyses were performed in the ion mobility-enhanced data-independent acquisition mode with drift time-specific collision energies as described ([@bib14]; [@bib15]). Specifically, a novel data acquisition strategy with dynamic range enhancement (DRE) was used, in which a deflection lens cycles between full and reduced ion transmission during one scan. This method provides an optimal trade-off between identification rate (i.e. proteome depth) and dynamic range for correct quantification of high-abundant myelin proteins. Continuum LC-MS data were processed using Waters ProteinLynx Global Server (PLGS) version 3.0.2 and database searches were performed against the UniProtKB/Swiss-Prot mouse proteome (release 2016--07, 16806 entries) to which the sequence information for E. coli. Chaperone protein ClpB, porcine trypsin, and the reversed sequence of each entry was added. The false discovery rate (FDR) for protein identification was set to 1% threshold. As to the experimental design, myelin protein fractions from the CNS of three mice per condition (*Anln* cKO, Ctrl) were processed with replicate digestion, resulting in two technical replicates per biological replicate and thus in a total of 12 LC-MS runs to be compared in the freely available software ISOQuant ([www.isoquant.net](http://www.isoquant.net)). This post-identification analysis included retention time alignment, exact mass and retention time (EMRT) and ion mobility clustering, data normalization, isoform/homology filtering, and calculation of absolute in-sample amounts for each detected protein as described ([@bib1]; [@bib39]). FDR for both peptides and proteins was set to 1% threshold and only proteins reported by at least two peptides were quantified using the TOP3 method. The parts per million (ppm) abundance values (i.e. the relative amount (w/w) of each protein in respect to the sum over all detected proteins) were log2-transformed and significant changes in protein abundance were detected by moderated t-statistics with an empirical Bayes approach and false discovery (FDR)-based correction for multiple comparisons performed in RStudio ([@bib1]; [@bib34]). The genotype-dependent relative abundance of a protein in myelin was compared with high stringency and accepted as altered if both statistically significant (q-value \<0.01) and exceeding a regulation factor threshold of 2-fold.

Lipid extraction and PtdIns(4,5)P~2~ measurement {#s3-7}
------------------------------------------------

Purified myelin was thawed on ice in 1 ml of an acidic extraction solvent ([@bib10]) containing 36% (v/v) CH~3~OH, 36% (v/v) CHCl~3~, 18% (v/v) 2.4 M HCl, and 9% (v/v) 0.4 M EDTA in a glass reaction vial (73750--13100, Kimble-Chase, Meiningen, Germany). The material was ground to homogeneity using a rotating Douncer (IKA, Staufen, Germany) on ice. Samples were mixed and incubated for 2 hr at 4°C while shaking on a Cat-Ing shaker (Ballrechten, Germany, city). Phases were separated by centrifugation for 2 min at 600 *g*, and the organic phase was collected into a fresh glass tube. Samples were re-extracted twice with 500 µl of CHCl~3~. The combined organic phases were washed twice using 1.5 ml of 0.5 M HCl in 50% (v/v) CH~3~OH. The first aqueous phase was discarded; after the second washing step the organic phase was collected into a fresh glass tube. The lipid extracts were analyzed in a double-blind experiment for phosphatidylinositol (4,5)-bisphosphate (PtdIns(4,5)P~2~) using combined thin layer chromatography (TLC) and gas chromatography (GC) essentially as previously described ([@bib26]; [@bib37]). Briefly, myelin samples were subjected to TLC on silica S60 plates (Merck, Darmstadt, Germany) using a developing solvent of CHCl~3~:CH~3~OH:NH~4~OH:H~2~O (57:50:4:11 v/v/v/v) ([@bib57]). Lipids were identified by co-migration with authentic standards (5 μg; Avanti Polar Lipids, Alabaster, AL, USA), re-isolated and quantified according to their fatty acid content, as determined by GC. For GC analysis, re-isolated lipids were dissolved in MeOH/toluol (2:1 v/v), 5 μg of tripentadecanoin was added as an internal standard for quantification and the mixture transmethylated with 0.5 M sodium methoxide (Sigma-Aldrich, Munich, Germany) according to ([@bib30]). After 30 min incubation at room temperature, derivatization was terminated by adding 0.5 ml 5 M NaCl (Sigma-Aldrich, Munich, Germany) and 50 μl of 32% HCl (Carl Roth, Karlsruhe, Germany). Fatty acid methyl esters were extracted with 2 ml hexane (Carl Roth, Karlsruhe, Germany), the hexane phase was washed twice with 2 ml ddH~2~O and dried under streaming nitrogen. The lipid coat was resuspended in 10 μl acetonitrile (Carl-Roth, Karlsruhe, Germany) and transferred to GC vials (order number 702287.1, VWR, Darmstadt, Germany). GC analysis was performed using a GC2010plus gas chromatograph with flame ionization detection (Shimadzu, Jena, Germany) fitted with a DB-23 capillary column (30 m x 250 μm, 0.25 μm coating thickness; J and W, Agilent, Waldbronn, Germany). Helium flowed as a carrier gas at 1 ml min^−1^. Samples were injected at 220°C. The temperature gradient was 150°C for 1 min, 150--200°C at 8 °C min^−1^, 200--250°C at 25 °C min^−1^ and 250°C for 6 min as previously described ([@bib37]). Fatty acids were identified according to authentic standards and quantified relative to the internal standard using GC-solution software (Shimadzu, Jena, Germany).

Immunoblotting {#s3-8}
--------------

Immunoblotting was performed as described ([@bib55]; [@bib61]). Antibodies were specific for ANLN (Acris AP16165PU-N; 1:1000), SEPT2 (ProteinTech Group 11397--1-AP; 1:500), SEPT4 (IBL JP18987; 1:500), SEPT7 (IBL JP18991; 1:5000), SEPT8 (ProteinTech Group 11769--1-AP; 1:2500), MAG (([@bib20]); kindly provided by N. Schaeren-Wiemers, Basel; 1:500), PLP/DM20 (A431 (([@bib33]); 1:5000), cyclic nucleotide phosphodiesterase (CNP) (Sigma C5922; 1:1000), MOG (clone 8--18 C5 ([@bib43]); 1:5000; kindly provided by C. Linington, Glasgow), SIRT2 (abcam 67299; 1:500), CD9 (abcam ab92726; 1:2000), CA2 (([@bib23]; [@bib24]); 1:1000; kindly provided by S. Ghandour, Strasbourg), ATP1A1 (abcam ab7671; 1:2500), ATP1A3 (abcam ab2826; 1:1000), beta3-Tubulin (TUBB3/Tuj1) (Covance MMS-435P; 1:1000). Secondary HRP-coupled antibodies were anti-mouse (dianova 715-035-020; 1:1000), -rabbit (dianova 711-035-152; 1:1000), or -goat (dianova 705-035-003; 1:500). Immunoblots were scanned using the Intas ChemoCam system.

Quantitative RT-PCR {#s3-9}
-------------------

mRNA abundance was determined by qRT-PCR as described ([@bib45]; [@bib55]) using corpus callosi dissected from 4 months old male and female mice of the indicated genotypes. mRNA abundance was analyzed in relation to the mean of the standard *Ppia*, which did not differ between genotypes. Statistical analysis was performed in GraphPad Prism 6.0. Primers were specific for *Anln* (forward 5'-ACAATCCAAG GACAAACTTGC, reverse 5'- GCGTTCCAGG AAAGGCTTA, *Sept2* (forward 5'-TCCTGACTGA TCTCTACCCAGAA, reverse 5'-AAGCCTCTAT CTGGACAGTTCTTT), *Sept4* (forward 5'-ACTGACTTGT ACCGGGATCG, reverse 5'-TCTCCACGGT TTGCATGAT), *Sept7* (forward 5'-AGAGGAAGGC AGTATCCTTGG, reverse 5'-TTTCAAGTCC TGCATATGTGTTC), *Sept8* (forward 5'-CTGAGCCCCG GAGCCTGT, reverse 5'-CAATCCCAGT TTCGCCCACA), *Cdc42* (forward 5'-GCTGTCAAGT ATGTGGAGTGCT, reverse 5\'-GGCTCTTCTT CGGTTCTGG), *Rhob* (forward 5'-CAGACTGCCT GACATCTGCT, reverse 5\'-GTGCCCACGCT AATTCTCAG) and the standard *Ppia* (forward 5'-CACAAACGGT TCCCAGTTTT, reverse 5'-TTCCCAAAGA CCACATGCTT).

Nerve conduction velocity measurement {#s3-10}
-------------------------------------

Nerve conduction velocity in the CNS was measured in 6 months old anesthetized male mice in vivo as described ([@bib13]; [@bib55]).

Funding Information
===================

This paper was supported by the following grants:

-   http://dx.doi.org/10.13039/501100001659Deutsche Forschungsgemeinschaft WE2720/2-2 to Hauke B Werner.

-   http://dx.doi.org/10.13039/501100001659Deutsche Forschungsgemeinschaft WE2720/4-1 to Hauke B Werner.

-   http://dx.doi.org/10.13039/501100000781European Research Council Advanced Grant MyeliNano to Klaus-Armin Nave.

We thank A Fahrenholz, D Hesse, U Kutzke, C Nardis, T Ruhwedel and M Schindler for technical support, S Ghandour, C Linington and N Schaeren-Wiemers for antibodies, and S Tenzer for discussions. AMS was funded by the Cluster of Excellence and Deutsche Forschungsgemeinschaft (DFG) Research Center Nanoscale Microscopy and Molecular Physiology of the Brain (CNMPB). K-AN holds an ERC Advanced Grant ('MyeliNano'). This work is supported by the Deutsche Forschungsgemeinschaft (DFG) (Grants WE 2720/2--2 and WE 2720/4--1 to HBW).

Additional information {#s4}
======================

Reviewing editor, *eLife*.

No competing interests declared.

Investigation, Performed all experiments not specified below, conducted statistical analysis, contributed to analysis and interpretation of data, contributed to writing the manuscript and approved the version to be published.

Investigation, Contributed to conception and design of the study, contributed to writing the article and approved the version to be published.

Investigation, Performed, analyzed and interpreted the FIB-SEM, contributed to writing the article and approved the version to be published.

Investigation, Performed, analyzed and interpreted the electrophysiological measurements, contributed to writing the article and approved the version to be published.

Investigation, Performed and analyzed the PIP2 measurement, contributed to writing the article and approved the version to be published.

Supervision, Methodology, Analyzed and interpreted the PIP2 measurement, contributed to writing the article and approved the version to be published.

Investigation, Contributed to biochemical analysis, contributed to writing the article and approved the version to be published.

Supervision, Investigation, Performed, analyzed and interpreted the qRT-PCR, contributed to writing the article and approved the version to be published.

Supervision, Methodology, Contributed to analyzing and interpreting electron microscopy and FIB-SEM data, contributed to writing the article and approved the version to be published.

Investigation, Methodology, Performed, analyzed and interpreted the proteome analysis, contributed to writing the article and approved the version to be published.

Writing---review and editing, Contributed to designing experiments, contributed to writing the article and approved the version to be published.

Conceptualization, Supervision, Writing---original draft, Writing---review and editing, Conceived, designed and directed the study, analyzed and interpreted data, wrote the article and approved the version to be published.

Animal experimentation: All experiments were approved by the Niedersächsisches Landesamt für Verbraucherschutz und Lebensmittelsicherheit (license 33.19-42502-04-15/1833) in agreement with the German Animal Protection Law.

Additional files {#s5}
================

10.7554/eLife.43888.015

Data availability {#s6}
-----------------

All data are included in the manuscript and supporting files. A source data file is provided for Figure 3.

10.7554/eLife.43888.018

Decision letter

Stevens

Beth

Reviewing Editor

Boston Children\'s Hospital

United States

Lyons

David A

Reviewer

University of Edinburgh

United Kingdom

Macklin

Wendy B

Reviewer

University of Colorado Anschutz Medical Campus

United States

In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

\[Editors' note: minor issues and corrections have not been included, so there is not an accompanying Author response.\]

Congratulations, we are pleased to inform you that your article, \"Anillin facilitates septin assembly to prevent pathological outfoldings of central nervous system myelin\", has been accepted for publication in *eLife*.

This study represents an important advance on their previous study from these authors, identifying septins as crucial to the maintenance of mature myelin morphology in the CNS, and seems entirely appropriate for publication in *eLife* as a \'Research Advance\' paper. Here, the authors assess the role of the cytoskeletal adaptor anillin in CNS myelination: they convincingly show that anillin is expressed and localized similarly to septin in myelinating glia, and that its disruption leads to very specific effects on myelin maintenance. The authors further demonstrate that anillin appears essential to the localization of septin proteins to myelin itself, which is a key observation central to the premise that anillin is a key regulator of septin assembly for myelin maintenance. Specific reviewer comments are included below.

*Reviewer \#1:*

\"Anillin facilitates septin assembly to prevent pathological outfoldings of central nervous system myelin\", by Erwig et al., represents an important advance on their previous study identifying septins as crucial to the maintenance of mature myelin morphology in the central nervous system, and seems entirely appropriate for publication in *eLife*. In their new study, Erwig et al. assess the role of the cytoskeletal adaptor anillin in CNS myelination: they find that it is expressed and localised similarly to septin in myelinating glia, and that its disruption leads to very specific effects on myelin maintenance, i.e. the formation of myelin outfoldings. The authors further demonstrate that anillin appears essential to the localisation of septin proteins to myelin itself, which is a key observation central to the premise that anillin is a key regulator of septin assembly for myelin maintenance.

The experiments incorporate the generation and analyses of conditional knockout mice, biochemistry, mass spec analyses of myelin, robust assessments of protein localisation over time, detailed electron microscopic assessments of myelination in mutants, electrophysiological assessments of function, and 3D electron microscopy-based reconstructions of outfolding pathologies. The core analyses are carried out to the absolute highest standard, the presentation is clear, and the conclusions drawn entirely in line with the data, and further supported by additional controls, e.g. that dysregulation of nodes of Ranvier may contribute to conduction impairments.

I don\'t actually have any major criticisms at all. One can always ask for more analyses and deeper mechanistic probing, but to me this manuscript already provides an important advance and could be published as it is.

*Reviewer \#2:*

This group has previously suggested in a beautiful paper published in *eLife* that anillin and septins form filaments along the myelin unit, which serves to maintain the normal compact organization of the myelin internode. They also convincingly showed that the absence of one of the septins results in aberrant sheath extension and the formation of myelin outfolding. In the current work, they examine the role of the adapter protein anillin which associates with septins and show that genetic deletion of the corresponding gene results in a similar neuropathology to mice lacking Sept8 (i.e., about 3% of the fibers exhibit myelin outfolding). They also found that the absence of anillin causes reduced expression of several cytoskeletal proteins including septins, as well as reduced level of phosphoinositides. They conclude that anillin is required for a septin-based scaffold of the myelin sheath.

*Reviewer \#3:*

This study by Erwig et al. focuses on the impact of septin assembly in central nervous system myelin. In an earlier *eLife* paper (Patzig et al., 2016), this group demonstrated that the loss of septins in myelin results in outfoldings of myelin, and that a septin-interacting protein, anillin, was also downregulated. This manuscript takes that observation further, demonstrating that conditional deletion of anillin results in essentially the same phenotype as the septin conditional deletion animals.

The data in this manuscript are well developed and convincing. The writing is straightforward. However, several points raise concerns as to whether this study moves the field forward significantly. The interaction of septins and anillin has been established for at least 15 years, and in many papers the concept that anillin \"instructs\" septin filament assembly is presented. Thus, the observation that loss of anillin acts comparably to that of septins is not unexpected. The involvement of anillin in septin filament assembly in myelin was clearly established in the earlier Patzig et al. paper, where many virtually identical analyses were conducted, demonstrating, for example, that the loss of septins induced loss of anillin protein but not RNA, and here, the loss of anillin induces loss of septin proteins but not RNA. This study clearly presents new information and as noted above the studies were executed well. Nevertheless, the new data primarily confirm published work showing that anillin is involved in septin organization in a number of cells, and the earlier Patzig study indicating that septin assembly including the involvement of anillin is crucial for myelin structure, i.e. it prevents the inappropriate outfolding of compacted myelin.

One element of this and the earlier Patzig study that is unexpected is that conduction velocity is altered at P75 in both types of septin/anillin knockouts but there is no obvious axonal pathology. Nevertheless, in both sets of animals the myelin outfoldings dramatically increase as the animals age. One unaddressed question is whether there is axonal pathology or greater conduction velocity change in 6M or older animals when myelin outfoldings increase.

Overall, this is a solid study, extending the earlier work of this group focused on the role of the septin assembly in myelin structure. However, the myelin outfolding outcome in mice conditionally deleted for anillin is not unexpected, and no significantly greater insight is provided by this study, with respect to understanding how septin assemblies regulate and prevent such outfoldings.
